Iteration Is a Blood Sport

Nothing says innovation quite like a five-year planning exercise to determine whether a technology invented last Tuesday might work. Add three committees, six consultants, a sensitivity analysis, and a lawyer to certify the conclusions, and you have the modern corporate miracle: spending millions to postpone the moment someone might actually have to build something. Progress, naturally, remains a strategic priority.
